CLINICAL_TRIALS
trial_result
· 2013-07-26
Clinical Trial Update: Aminocamptothecin in Treating Patients With T-cell Lymphoma [Phase 2]
Summary
Update on a Phase 2 trial evaluating aminocamptothecin in patients with T-cell lymphoma, noting completed status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Lymphoma | Phase 2 | Status: COMPLETED